【ChiCTR2200063370】Effectiveness of telehealth in preventive care: A randomised controlled trial of tele-exercise programme involving elderly with possible sarcopenia or at risk of fall
ChiCTR2200063370
尚未开始
/
/
/
2022-09-05
/
/
possible sarcopenia or at risk of fall
Effectiveness of telehealth in preventive care: A randomised controlled trial of tele-exercise programme involving elderly with possible sarcopenia or at risk of fall
Effectiveness of telehealth in preventive care: A randomised controlled trial of tele-exercise programme involving elderly with possible sarcopenia or at risk of fall
Primary objective 1. to evaluate the effectiveness of tele-exercise on physical function and exercise adherence among the elderly with possible sarcopenia or at risk of fall in comparison with a community-based group. Secondary objectives 2. To evaluate the elderly’s experience with tele-exercise, with an emphasis on their psychological welfare, social wellbeing, and acceptance of the telehealth approach.
整群随机抽样
Ⅰ期
In order to avoid contamination among recruited subjects from the 10 community centres, subjects were randomized by locations using a simple random drawing procedure.
Assessors will be blinded for the treatment of the participants.
Health and Medical Research Fund, Health Bureau, The Government of the Hong Kong Special Administrative Region
/
48
/
2022-07-04
2024-07-03
/
1. permanent residents of Hong Kong 2. aged 65 years or above living independently at home 3. diagnosed with possible sarcopenia and/or having either a fall in the past year or fear of falling with a score of >= 20 points on FES-I 4. able to speak and listen to Cantonese 5. able to walk without mobility aids in their home;
请登录查看1. diagnosed with dementia or cognitive impairment 2. severe vision impairments that do not permit the using of tablet, reading of the exercise-booklet, and completing the activity diaries 3. unable to pass the preparticipation Health Screening of American College of Sport Medicine (ACSM) 4. regular physical activities in the past 6 months based on the definition of WHO (Word Health Organization 2020).;
请登录查看College of Professional and Continuing Education, The Hong Kong Polytechnic University
/
College of Professional and Continuing Education, The Hong Kong Polytechnic University的其他临床试验
College of Professional and Continuing Education, The Hong Kong Polytechnic University的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 60
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

